Expression of human aldo-keto reductase 1C2 in cell lines of peritoneal endometriosis: Potential implications in metabolism of progesterone and dydrogesterone and inhibition by progestins

article OA: green CC0 ⤵ 2 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-07

This study investigated the expression of human aldo-keto reductase 1C2 in peritoneal endometriosis cell lines, finding its potential involvement in progesterone and dydrogesterone metabolism and inhibition by progestins.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Dydrogesterone Endometriosis Hydroxysteroid Dehydrogenases Hydroxysteroid Dehydrogenases Peritoneum Progesterone Progestins 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific) Catalytic Domain Cell Line Dihydrotestosterone Dihydrotestosterone Dydrogesterone Dydrogesterone Endometriosis Endometriosis Female Humans Hydroxysteroid Dehydrogenases Hydroxysteroid Dehydrogenases

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (38)

Cited by (2)

SciLite annotations

organisms 2
human human
chemicals 17
progesterone dydrogesterone progestin progesterone progestin progesterone progestin dydrogesterone progestin progesterone medroxyprogesterone delta(1)-dihydrotestosterone progestin dydrogesterone medroxyprogesterone acetate dydrogesterone

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:16:23.388809+00:00
scilite
last seen: 2026-05-18T04:25:29.313245+00:00
License: CC0 · commercial use OK